Tfc Financial Management Veracyte, Inc. Transaction History

Tfc Financial Management

$629 Million
Q3 2024

A detailed history of Tfc Financial Management transactions in Veracyte, Inc. stock. As of the latest transaction made, Tfc Financial Management holds 1 shares of VCYT stock, worth $41. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$41

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 24, 2024	BUY	$21.0 - $35.25 $21 - $35	1 New	1 $0
Q1 2024 Apr 30, 2024	BUY	$21.0 - $29.1 $21 - $29	1 New	1 $0

Others Institutions Holding VCYT

# of Institutions

307

Shares Held

81.6M

Call Options Held

134K

Put Options Held

13.3K

Black Rock Inc. New York, NY

7.79M
Shares

$324 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

7.75M
Shares

$322 Million
0.0% of portfolio
Artisan Partners Limited Partnership Milwaukee, WI

5.02M
Shares

$209 Million
0.27% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

4.92M
Shares

$204 Million
1.59% of portfolio
Wellington Management Group LLP Boston, MA

4.23M
Shares

$176 Million
0.03% of portfolio

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.

Account